Methylene Blue FAQ | 183+ Questions Answered | Nutricel

Methylene Blue
FAQ

183+ answers to every question people actually search, brain fog, long COVID, ADHD, drug interactions, dosing, quality, and research. Typo-tolerant search.

Filter
🔍

No results for

Try a different keyword or select a category above.

References & Sources

20 citations

Sources & References

Peer-reviewed studies and clinical references cited in this FAQ. All studies are indexed in PubMed or published in peer-reviewed journals. Nutricel products are not intended to diagnose, treat, cure, or prevent any disease.

Important: This FAQ is for educational and informational purposes only. Nothing on this page constitutes medical advice. Always consult a licensed healthcare provider before beginning any supplement, especially if you take prescription medications or have a medical condition.

Cognitive Function & Memory

  1. Rodriguez, P., et al. (2017). Methylene blue modulates functional connectivity in the human brain. Brain Imaging and Behavior, 11, 640-648. doi.org/10.1007/s11682-016-9541-6
  2. Riha, P.D., et al. (2005). Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. European Journal of Pharmacology, 511(2-3), 151-158. doi.org/10.1016/j.ejphar.2005.02.001
  3. Lin, A.L., et al. (2012). Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS ONE, 7(10), e46585. doi.org/10.1371/journal.pone.0046585

Mitochondrial Function & Energy

  1. Tucker, D., Lu, Y., & Zhang, Q. (2018). From mitochondrial function to neuroprotection: an emerging role for methylene blue. Molecular Neurobiology, 55(6), 5137-5153. doi.org/10.1007/s12035-017-0712-2
  2. Duicu, O.M., et al. (2017). Methylene blue improves mitochondrial respiration and decreases oxidative stress in a substrate-dependent manner in diabetic rat hearts. Canadian Journal of Physiology and Pharmacology, 95(11), 1376-1382. doi.org/10.1139/cjpp-2017-0074
  3. Svab, G., et al. (2021). Methylene blue bridges the inhibition and produces unusual respiratory changes in complex III-inhibited mitochondria. Antioxidants, 10(2), 305. doi.org/10.3390/antiox10020305

Aging & Cellular Senescence

  1. Atamna, H., et al. (2008). Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB Journal, 22(3), 703-712. doi.org/10.1096/fj.07-9610com
  2. Sekhar, R.V., et al. (2022). Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and aging hallmarks. Clinical and Translational Medicine, 12(6). doi.org/10.1002/ctm2.372
  3. Kumar, P., et al. (2023). Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks. Journals of Gerontology, 78(1), 75-89. doi.org/10.1093/gerona/glac135

Neurodegeneration & Neuroprotection

  1. Soeda, Y., et al. (2019). Methylene blue inhibits formation of tau fibrils but not granular tau oligomers. Journal of Alzheimer's Disease, 68(4), 1677-1686. doi.org/10.3233/JAD-181001
  2. Zhou, L., et al. (2019). Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice. Acta Neuropathologica Communications, 7, 210. doi.org/10.1186/s40478-019-0856-6
  3. Gonzalez-Lima, F., & Auchter, A. (2015). Protection against neurodegeneration with low-dose methylene blue and near-infrared light. Frontiers in Cellular Neuroscience, 9, 179. doi.org/10.3389/fncel.2015.00179
  4. Auchter, A.M., et al. (2020). Methylene blue preserves cytochrome oxidase activity and prevents neurodegeneration and memory impairment in rats with chronic cerebral hypoperfusion. Frontiers in Cellular Neuroscience, 14, 130. doi.org/10.3389/fncel.2020.00130

Mood & Psychiatric Applications

  1. Alda, M., et al. (2017). Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. British Journal of Psychiatry, 210(1), 54-60. doi.org/10.1192/bjp.bp.115.173930
  2. Telch, M.J., et al. (2014). Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. American Journal of Psychiatry, 171(10), 1091-1098. doi.org/10.1176/appi.ajp.2014.13101407

Pharmacokinetics & Safety

  1. Walter-Sack, I., et al. (2009). High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology, 65(2), 179-189. doi.org/10.1007/s00228-008-0563-1
  2. Ginimuge, P.R., & Jyothi, S.D. (2010). Methylene blue: revisited. Journal of Anaesthesiology Clinical Pharmacology, 26(4), 517-520. doi.org/10.4103/0970-9185.74308
  3. Wright, R.O., Lewander, W.J., & Woolf, A.D. (1999). Methemoglobinemia: etiology, pharmacology, and clinical management. Annals of Emergency Medicine, 34(5), 646-656. doi.org/10.1016/S0196-0644(99)70167-8

Regulatory & Pharmaceutical Standards

  1. United States Pharmacopeia (USP). Methylene Blue USP Monograph. usp.org
  2. World Health Organization (2023). WHO Model List of Essential Medicines, 23rd Edition. who.int
  3. Eurofins Scientific. ISO/IEC 17025 Accredited Laboratory Testing. eurofins.com